CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

1 year ago

Strengthened Cash, Strategic Refocus and Pipeline Progress Define Transformative Quarter€400 million upfront payment from restructured GSK collaboration reflected in financials,…

Yunu Welcomes Veteran Life Sciences Commercial Leader Patrick McNamara

1 year ago

McNamara's extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies brings a wealth of expertise…

Quest Responds to the Surge in FDA Recalls by Strengthening Industry-Leading Field Corrective Action Services

1 year ago

Quest International's Expanded FCA Resources Offer Medical Device OEMs Timely, Reliable Support Amid Rising FDA RecallsIRVINE, CA / ACCESSWIRE /…

Noble Capital Markets Initiates Equity Research Coverage on Zomedica

1 year ago

ANN ARBOR, MI / ACCESSWIRE / November 12, 2024 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care…

FDA Clears Magstim Horizon INSPIRE Transcranial Magnetic Stimulation System to treat Depression, OCD, Anxious Depression

1 year ago

Next Generation Compact TMS System Offers Physicians, Nurse Practitioners, New Easy to Use, Affordable Effective TreatmentMINNEAPOLIS and CARMARTHENSHIRE, United Kingdom,…

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues

1 year ago

Conference call will be held today, Tuesday, November 12 at 9:00 am ETCARMEL, Ind., Nov. 12, 2024 (GLOBE NEWSWIRE) --…

Maravai LifeSciences Announces November 2024 Investor Conference Schedule

1 year ago

SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents…

Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer

1 year ago

Cellectar broadens global manufacturing network in preparation for potential commercialization of Iopofosine I 131 in 2025INDIANAPOLIS and FLORHAM PARK, N.J.,…

Nkarta to Participate in an Upcoming Investor Conference

1 year ago

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural…

Intercept Receives Complete Response Letter from FDA Addressing OCALIVA supplemental New Drug Application (sNDA)  

1 year ago

MORRISTOWN, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., today…